Skip to main content
. Author manuscript; available in PMC: 2012 Sep 22.
Published in final edited form as: Adv Mater. 2011 Aug 15;23(36):H217–H247. doi: 10.1002/adma.201102313

Figure 13.

Figure 13

T2-weighted image of tumor-bearing mouse injected with pluronic F127-modifed magnetic NPs. Enhanced contrast in the tumor (denoted by arrow) is apparent 4 min after the initial injection and is more pronounced at 68 min after a second injection of the MNPs. Images were analyzed for signal intensity in the tumor with Amira software (Visage Imaging, Inc., San Diego, CA). Reproduced with permission.[208] Copyright 2009 Elsevier.